1. Home
  2. CUE vs BMR Comparison

CUE vs BMR Comparison

Compare CUE & BMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CUE
  • BMR
  • Stock Information
  • Founded
  • CUE 2014
  • BMR 2009
  • Country
  • CUE United States
  • BMR Israel
  • Employees
  • CUE N/A
  • BMR N/A
  • Industry
  • CUE Biotechnology: Pharmaceutical Preparations
  • BMR Computer Software: Prepackaged Software
  • Sector
  • CUE Health Care
  • BMR Technology
  • Exchange
  • CUE Nasdaq
  • BMR Nasdaq
  • Market Cap
  • CUE 58.9M
  • BMR 59.3M
  • IPO Year
  • CUE 2018
  • BMR 2023
  • Fundamental
  • Price
  • CUE $0.78
  • BMR $2.64
  • Analyst Decision
  • CUE Strong Buy
  • BMR
  • Analyst Count
  • CUE 3
  • BMR 0
  • Target Price
  • CUE $3.00
  • BMR N/A
  • AVG Volume (30 Days)
  • CUE 158.3K
  • BMR 56.3K
  • Earning Date
  • CUE 05-20-2025
  • BMR 05-20-2025
  • Dividend Yield
  • CUE N/A
  • BMR N/A
  • EPS Growth
  • CUE N/A
  • BMR N/A
  • EPS
  • CUE N/A
  • BMR N/A
  • Revenue
  • CUE $9,287,000.00
  • BMR $3,064,000.00
  • Revenue This Year
  • CUE N/A
  • BMR N/A
  • Revenue Next Year
  • CUE $25.99
  • BMR N/A
  • P/E Ratio
  • CUE N/A
  • BMR N/A
  • Revenue Growth
  • CUE 69.16
  • BMR 5.33
  • 52 Week Low
  • CUE $0.45
  • BMR $1.86
  • 52 Week High
  • CUE $2.26
  • BMR $6.71
  • Technical
  • Relative Strength Index (RSI)
  • CUE 46.03
  • BMR 54.93
  • Support Level
  • CUE $0.71
  • BMR $2.57
  • Resistance Level
  • CUE $0.78
  • BMR $2.89
  • Average True Range (ATR)
  • CUE 0.06
  • BMR 0.19
  • MACD
  • CUE 0.01
  • BMR 0.04
  • Stochastic Oscillator
  • CUE 46.11
  • BMR 68.39

About CUE Cue Biopharma Inc.

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.

About BMR Beamr Imaging Ltd.

Beamr Imaging Ltd is a video technology and image science software company. It is an innovator of video encoding, transcoding, and optimization solutions that enable high quality, performance, and unmatched bitrate efficiency for video and images. The company is conducted through one operating segment, the optimization technology for video and photo compression. The company operates in Israel, the United States, and the rest of the world, it derives a majority of its revenue from the United States.

Share on Social Networks: